Consulting firm McKinsey to pay $650 million to end opioid criminal probe
The investigation stems from the company’s work advising Purdue Pharma on how to “turbocharge” sales of the blockbuster opioid OxyContin, officials said.
New England Cable News on MSN3d
McKinsey & Company to pay $650 million to settle U.S. opioid consulting probe
The painkillers have helped fuel the deadly U.S. opioid epidemic. According to Christopher R. Kavanaugh, U.S. Attorney for ...